Advertisement
Screener

TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax

1.5 / 5 stars · 18/60 Roast Me

TONIX PHARMACEUTICALS HOLDING CORP. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax

TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of -$8.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2021-08-09

  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2021-06-30 was -$8.00K.
  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2021-03-31 was -$1.00K.
  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2020-09-30 was $5.00K.
  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2020-06-30 was -$9.00K.
  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2020 was -$16.00K.
  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2019 was -$5.00K.
  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2018 was -$29.00K.
  • TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2017 was -$5.00K.
Period endOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month as first filedOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 79 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 82 month
2021-06-30-$8.00K
10-Q · filed 2021-08-09
-$9.00K
derived: sum of 2 quarters · filed 2021-08-09
2021-03-31-$1.00K
10-Q · filed 2021-08-09
2020-12-31-$16.00K
10-K · filed 2021-03-15
2020-09-30$5.00K
10-Q · filed 2020-11-09
-$4.00K
derived: sum of 2 quarters · filed 2021-08-09
-$18.00K
derived: sum of 3 quarters · filed 2021-08-09
2020-06-30-$9.00K
10-Q · filed 2021-08-09
-$23.00K
derived: sum of 2 quarters · filed 2021-08-09
2020-03-31-$14.00K
10-Q · filed 2021-08-09
2019-12-31-$5.00K
10-K · filed 2021-03-15
2019-09-30-$3.00K
10-Q · filed 2020-11-09
2019-03-31$2.00K
10-Q · filed 2020-11-09
-$10.00K
derived: sum of 2 quarters · filed 2020-11-09
-$5.00K
derived: sum of 3 quarters · filed 2020-11-09
-$26.00K
derived: sum of 4 quarters · filed 2020-11-09
2018-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24
-$7.00K
derived: sum of 2 quarters · filed 2020-03-24
-$28.00K
derived: sum of 3 quarters · filed 2020-03-24
-$29.00K
10-K · filed 2020-03-24
2018-09-30$5.00K
10-Q · filed 2019-11-08
-$16.00K
derived: sum of 2 quarters · filed 2019-11-08
-$17.00K
10-Q · filed 2018-11-09
-$19.00K
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$21.00K
10-Q · filed 2019-11-08
-$22.00K
10-Q · filed 2018-08-13
-$24.00K
derived: sum of 3 quarters · filed 2019-11-08
-$25.00K
derived: sum of 4 quarters · filed 2019-11-08
2018-03-31-$1.00K
10-Q · filed 2019-11-08
-$3.00K
derived: sum of 2 quarters · filed 2019-11-08
-$4.00K
derived: sum of 3 quarters · filed 2019-11-08
-$5.00K
derived: sum of 4 quarters · filed 2019-11-08
2017-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$3.00K
derived: sum of 2 quarters · filed 2019-03-18
-$4.00K
derived: sum of 3 quarters · filed 2019-03-18
-$5.00K
10-K · filed 2019-03-18
2017-09-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
-$2.00K
derived: sum of 2 quarters · filed 2017-11-06
-$3.00K
10-Q · filed 2017-11-06
2017-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11
-$2.00K
10-Q · filed 2017-08-11
2017-03-31-$1.00K
10-Q · filed 2017-05-12
2016-12-31-$17.00K
10-K · filed 2018-03-09
2016-03-31-$18.00K
10-Q · filed 2016-05-06
-$13.00K
derived: sum of 2 quarters · filed 2016-05-06
-$22.00K
derived: sum of 3 quarters · filed 2016-05-06
-$23.00K
derived: sum of 4 quarters · filed 2016-05-06
2015-12-31$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03
-$4.00K
derived: sum of 2 quarters · filed 2016-03-03
-$5.00K
derived: sum of 3 quarters · filed 2016-03-03
-$8.00K
10-K · filed 2016-03-03
2015-09-30-$9.00K
10-Q · filed 2015-11-06
-$10.00K
derived: sum of 2 quarters · filed 2015-11-06
-$13.00K
10-Q · filed 2015-11-06
-$14.00K
derived: sum of 4 quarters · filed 2016-05-06
2015-06-30-$1.00K
10-Q · filed 2015-08-07
-$4.00K
10-Q · filed 2015-08-07
-$5.00K
derived: sum of 3 quarters · filed 2016-05-06
-$4.00K
derived: sum of 4 quarters · filed 2016-05-06
2015-03-31-$3.00K
10-Q · filed 2016-05-06
-$4.00K
derived: sum of 2 quarters · filed 2016-05-06
-$3.00K
derived: sum of 3 quarters · filed 2016-05-06
-$6.00K
derived: sum of 4 quarters · filed 2016-05-06
2014-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03
$0.00
derived: sum of 2 quarters · filed 2016-03-03
-$3.00K
derived: sum of 3 quarters · filed 2016-03-03
-$3.00K
10-K · filed 2016-03-03
2014-09-30$1.00K
10-Q · filed 2015-11-06
-$2.00K
derived: sum of 2 quarters · filed 2015-11-06
-$2.00K
10-Q · filed 2015-11-06
-$3.00K
derived: sum of 4 quarters · filed 2016-03-03
2014-06-30-$3.00K
10-Q · filed 2015-08-07
-$5.00K
10-Q · filed 2015-08-07
-$4.00K
derived: sum of 3 quarters · filed 2016-03-03
-$4.00K
derived: sum of 4 quarters · filed 2016-03-03
2014-03-31-$2.00K
10-Q · filed 2015-05-08
-$1.00K
derived: sum of 2 quarters · filed 2016-03-03
-$1.00K
derived: sum of 3 quarters · filed 2016-03-03
-$1.00K
derived: sum of 4 quarters · filed 2016-03-03
-$1.00K
10-Q · filed 2014-05-13
2013-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03
$1.00K
derived: sum of 2 quarters · filed 2016-03-03
$1.00K
derived: sum of 3 quarters · filed 2016-03-03
$1.00K
10-K · filed 2016-03-03
-$1.00K
10-K · filed 2014-03-28
-$1.00K
10-K · filed 2014-03-28
2013-09-30$0.00
10-Q · filed 2014-11-07
$0.00
derived: sum of 2 quarters · filed 2014-11-07
$0.00
10-Q · filed 2014-11-07
2013-06-30$0.00
10-Q · filed 2014-08-08
$0.00
10-Q · filed 2014-08-08
2013-03-31$0.00
10-Q · filed 2014-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Annexon, Inc. (ANNX)United States$0.147B-4.22
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91